NASDAQ : AMIX
Autonomix Medical, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 1.81 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.55M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 9.32M | 9.89M | 6.86M | 5.25M | 1.25M | 13.59M |
| Research & Development | 7.07M | 7.14M | 4.72M | 2.23M | 745.00K | 4.07K |
| Operating Expenses | 16.38M | 17.03M | 11.59M | 7.47M | 1.99M | 13.59M |
| Operating Income | -16.38M | -17.03M | -11.59M | -7.47M | -1.99M | -13.59M |
| Interest Expense | -176.00K | -79.00K | -218.09K | |||
| Interest & Investment Income | 277.00K | 319.00K | 354.00K | 127.00K | ||
| Other Non Operating Income (Expenses) | -8.00M | 313.83K | ||||
| EBT Excluding Unusual Items | -16.11M | -16.71M | -11.41M | -15.43M | -1.99M | -13.50M |
| Other Unusual Items | 169.82K | |||||
| Pretax Income | -16.11M | -16.71M | -11.41M | -15.43M | -1.99M | -13.33M |
| Net Income | -16.11M | -16.71M | -11.41M | -15.43M | -1.99M | -13.33M |
| Preferred Dividends & Other Adjustments | -486.89K | |||||
| Net Income to Common | -16.11M | -16.71M | -11.41M | -15.43M | -1.99M | -12.84M |
| Shares Outstanding (Basic) | 442.81K | 343.65K | 84.11K | 49.56K | 28.63K | |
| Shares Outstanding (Diluted) | 442.81K | 343.65K | 84.11K | 49.56K | 28.63K | |
| EPS (Basic) | -36.37 | -48.64 | -135.65 | -311.27 | -69.52 | |
| EPS (Diluted) | -36.37 | -48.64 | -135.65 | -311.27 | -69.52 | |
| Free Cash Flow | -13.23M | -12.29M | -8.27M | -6.67M | -1.85M | -387.31K |
| Free Cash Flow Per Share | -29.88 | -35.77 | -98.34 | -134.53 | -64.77 | |
| EBITDA | -16.37M | -17.02M | -11.40M | -7.39M | ||
| D&A For EBITDA | 12.00K | 12.00K | 183.00K | 81.00K | ||
| EBIT | -16.38M | -17.03M | -11.59M | -7.47M | -1.99M | -13.59M |
| Advertising Expenses | 1.80M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.46M | 7.00M | 9.14M | 8.61M | 865.00K | 2.04M |
| Cash & Short-Term Investments | 3.46M | 7.00M | 9.14M | 8.61M | 865.00K | 2.04M |
| Other Current Assets | 577.00K | 473.00K | 783.00K | 8.73K | ||
| Total Current Assets | 3.96M | 7.58M | 9.61M | 9.39M | 865.00K | 2.05M |
| Property, Plant & Equipment | 16.00K | 19.00K | 21.00K | 16.00K | ||
| Long-Term Deferred Charges | 176.00K | |||||
| Total Assets | 3.98M | 7.60M | 9.81M | 9.41M | 865.00K | 2.05M |
| Accounts Payable | 371.00K | 700.00K | 676.00K | 492.00K | 173.00K | 91.62K |
| Accrued Expenses | 447.00K | 1.00M | 1.03M | 285.00K | 48.00K | 1.62K |
| Total Current Liabilities | 818.00K | 1.71M | 1.71M | 777.00K | 221.00K | 93.24K |
| Long-Term Debt | 1.00M | |||||
| Total Liabilities | 818.00K | 1.71M | 1.71M | 1.78M | 221.00K | 93.24K |
| Common Stock | 1.00K | 11.00K | 2.00K | 1.00K | 12.00K | 12.00K |
| Additional Paid-In Capital | 72.98M | 72.98M | 58.48M | 46.60M | 24.18M | 23.50M |
| Retained Earnings | -69.82M | -67.09M | -50.38M | -38.97M | -23.54M | -21.55M |
| Shareholders' Equity | 3.16M | 5.89M | 8.10M | 7.63M | 644.00K | 1.96M |
| Total Liabilities & Equity | 3.98M | 7.60M | 9.81M | 9.41M | 865.00K | 2.05M |
| Total Debt | 1.00M | |||||
| Net Cash (Debt) | 3.46M | 7.00M | 9.14M | 7.61M | 865.00K | 2.04M |
| Net Cash Per Share | 7.81 | 20.38 | 108.61 | 153.48 | 30.22 | |
| Filing Date Shares Outstanding | 971.04K | 543.30K | 132.40K | 44.87K | 42.28K | |
| Total Common Shares Outstanding | 542.31K | 543.30K | 118.91K | 44.87K | 29.37K | |
| Working Capital | 3.15M | 5.88M | 7.90M | 8.61M | 644.00K | 1.96M |
| Book Value Per Share | 5.83 | 10.85 | 68.11 | 169.99 | 21.92 | |
| Tangible Book Value | 3.16M | 5.89M | 8.10M | 7.63M | 644.00K | 1.96M |
| Tangible Book Value Per Share | 5.83 | 10.85 | 68.11 | 169.99 | 21.92 |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -16.11M | -16.71M | -11.41M | -15.43M | -1.99M | -13.33M |
| Depreciation & Amortization | 12.00K | 12.00K | 183.00K | 81.00K | ||
| Other Amortization | 53.81K | |||||
| Stock-Based Compensation | 143.00K | 529.00K | 1.63M | 618.00K | 13.17M | |
| Other Operating Activities | 4.00M | 4.00M | 101.00K | 8.00M | -483.65K | |
| Change in Accounts Payable | -445.00K | 24.00K | 184.00K | 320.00K | 81.00K | 87.08K |
| Change in Other Net Operating Assets | -825.00K | -131.00K | 1.06M | -241.00K | 55.00K | 117.33K |
| Operating Cash Flow | -13.22M | -12.28M | -8.26M | -6.65M | -1.85M | -387.31K |
| Capital Expenditures | -10.00K | -10.00K | -14.00K | -19.00K | ||
| Investing Cash Flow | -10.00K | -10.00K | -14.00K | -19.00K | ||
| Short-Term Debt Issued | 400.00K | |||||
| Long-Term Debt Issued | 2.00M | 136.00K | ||||
| Total Debt Issued | 2.00M | 536.00K | ||||
| Net Debt Issued (Repaid) | 2.00M | 536.00K | ||||
| Issuance of Common Stock | 8.96M | 11.08M | 10.03M | 13.71M | 675.00K | 2.00M |
| Other Financing Activities | -853.00K | -917.00K | -1.23M | -1.30M | -110.48K | |
| Financing Cash Flow | 8.10M | 10.16M | 8.80M | 14.41M | 675.00K | 2.43M |
| Net Cash Flow | -5.13M | -2.13M | 528.00K | 7.74M | -1.18M | 2.04M |
| Free Cash Flow | -13.23M | -12.29M | -8.27M | -6.67M | -1.85M | -387.31K |
| Free Cash Flow Per Share | -29.88 | -35.77 | -98.34 | -134.53 | -64.77 | |
| Levered Free Cash Flow | -7.62M | -6.49M | -4.32M | -4.27M | -1.11M | |
| Unlevered Free Cash Flow | -7.62M | -6.49M | -4.21M | -4.22M | -1.11M | |
| Change in Working Capital | -1.27M | -107.00K | 1.24M | 79.00K | 136.00K | 204.41K |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.55M | 4.45M | 4.31M | 56.81M | ||
| Enterprise Value | 87.49K | -5.48M | -6.38M | 57.05M | ||
| Last Close Price | 1.81 | 8.19 | 36.75 | 1,268.40 | ||
| PB Ratio | 0.31 | 0.76 | 0.53 | 7.45 | ||
| P/TBV Ratio | 1.12 | 0.76 | 0.53 | 7.45 | ||
| Debt / Equity Ratio | 0.13 | |||||
| Net Debt / Equity Ratio | -1.09 | -1.19 | -1.13 | -1.00 | -1.34 | -1.04 |
| Net Debt / EBITDA Ratio | 0.21 | 0.41 | 0.80 | 1.03 | ||
| Net Debt / FCF Ratio | 0.26 | 0.57 | 1.10 | 1.14 | 0.47 | 5.28 |
| Quick Ratio | 4.23 | 4.11 | 5.35 | 11.08 | 3.91 | 21.92 |
| Current Ratio | 4.85 | 4.45 | 5.63 | 12.09 | 3.91 | 22.02 |
| Return on Equity (ROE) | -315.99% | -238.89% | -145.10% | -372.97% | -152.87% | |
| Return on Assets (ROA) | -157.81% | -122.33% | -75.39% | -90.95% | -85.25% | |
| Return on Capital Employed (ROCE) | -518.10% | -289.00% | -143.10% | -86.60% | -309.00% | -693.80% |
| Earnings Yield | -2,009.51% | -375.55% | -264.72% | -27.15% | ||
| FCF Yield | -373.00% | -276.18% | -191.92% | -11.74% | ||
| Buyback Yield / Dilution | -316.60% | -308.55% | -69.73% | -73.12% |